This news will help Per
Parents don’t want to commit to Sareptas gene therapy
until it proves efficacy..
This revolt by parents will also convince Clinicians that other therapies could be more beneficiary to their DMD loved ones..
- Forums
- ASX - By Stock
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
This news will help PerParents don’t want to commit to Sareptas...
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.001(1.25%) |
Mkt cap ! $83.97M |
Open | High | Low | Value | Volume |
8.3¢ | 8.4¢ | 8.1¢ | $84.93K | 1.029M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50582 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50582 | 0.081 |
10 | 929049 | 0.080 |
9 | 583071 | 0.079 |
5 | 682899 | 0.078 |
5 | 588042 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 40000 | 1 |
0.083 | 223162 | 4 |
0.084 | 721197 | 2 |
0.085 | 205343 | 3 |
0.086 | 250000 | 1 |
Last trade - 11.10am 11/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
SPONSORED BY The Market Online